Across TCGA pan-cancer cohorts, OR2T32P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR2T32P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where OR2T32P RNA is repressed in tumor relative to normal tissue. In most cancer types OR2T32P is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

THCA and PRAD are the cancer types where OR2T32P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR2T32P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.199	<.001	5	view →
PRAD	All	All	+0.058	.021	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: OR2T32P RNA expression & survival · all OR2T32P data types